North Carolina Construction News staff writer
Novartis, a global medicines company, announced plans Tuesday to expand its operations in North Carolina by building a new flagship manufacturing hub designed to produce the company’s key medicines entirely in the U.S.
The expansion is part of a broader $23 billion investment in U.S.-based infrastructure over the next five years, aimed at increasing manufacturing capacity and enabling 100 per cent of Novartis’ critical medicines to be produced end-to-end domestically…